Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-001175

Chief Executive Officer sold 4,967 shares at $5.33 ($26,464)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Rawcliffe Adrian Chief Executive Officer 2021-01-04 Sale −4,967 $5.33 $26,464 6,737 D
Open-market sales · 4,967 sh · avg $5.33 · $26,464
Loading xslF345X03/tm211506-1_4seq1.xml…